Lilly exec says MFN will affect company's obesity pill launch strategy in Europe: report

Eli Lilly plans to launch its oral obesity treatment Foundayo in Europe by the end of this year or early 2027, focusing on the direct-to-consumer market, Eli Lilly International president Patrik Jo | Eli Lilly will focus on the telehealth market when it launches its oral obesity treatment Foundayo in Europe, Patrik Jonsson, the company's International chief, told Reuters. He added that the company's plan to sell Foundayo through government channels will depend on the pricing implications of the most favored nations deal Lilly signed with the U.S. last year.